Read + Share
Cull G, Burger JA, Opat S, Gottlieb D, et al. Zanubrutinib for treatment-naive and relapsed/refractory chronic lymphocytic
leukaemia: long-term follow-up of the phase I/II AU-003 study. Br J Haematol 2022;196:1209-1218.
PMID: 34915592
|
 |
|
Cull G, Burger JA, Opat S, Gottlieb D, et al. Zanubrutinib for treatment-naive and relapsed/refractory chronic lymphocytic
leukaemia: long-term follow-up of the phase I/II AU-003 study. Br J Haematol 2022;196:1209-1218.
PMID: 34915592
|
|
|
|